The agreement was met with unionist opposition but it was the beginning of a process that ultimately secured peace, writes ...

Space debris is creating growing problems for space operations. It includes any artificial objects in orbit not operating as ...

Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 ...

Andrea Gaudenzi's two-week tournaments were meant to give players riches and transparency, but robbed them of their most ...

But after dozens of layoffs and a reorganization at Western Washington over the past year, that kind of service is no longer ...

Bionano Genomics, Inc. (NASDAQ: BNGO) Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats ...

Many global companies, including retailer Walmart, are continuing their climate policies, but often doing so quietly to avoid ...

“Earth with John Holden” featuring Aduro Clean Technologies Date: November 16 th, 2025 Website: https://earthtvseries.com/ ...

Commercially Launched ORLYNVAH™ in the United States in August 2025----Extended Cash Runway into Q2 2026----Company to host conference call ...

The Phase 2b ADAPTIVE trial is a randomized, placebo-controlled dose-finding study designed to evaluate the efficacy and safety of various dose regimens of IMG-007 in adults with moderate-to-severe AD ...

Phase 3 accelerated approval trial of IFx-2.0 as adjunctive therapy with Keytruda® (pembrolizumab) as a first-line therapy for advanced and metastatic Merkel cell ...

Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...